Cipesta 60Ml Oral Suspension 250Mg/5Ml
Original price was: ₹91.60.₹87.00Current price is: ₹87.00.
- Variations: Pc
- Discount Amount On Pc: £4.6
- Prescription Required: Yes
- Pc: £92.0
- Used For: Bacterial Infection
- Brand: Getz Pharma Pakistan
- Min Order Quantity: 100 units
- Min Order Price: ₹9160.00
Cipesta 60ml Oral Suspension, 250mg/5ml: Your Trusted Solution for Lower Respiratory Tract Infections
Are you looking for a reliable treatment for lower respiratory tract infections caused by Gram-negative bacteria? Our Cipesta 60ml Oral Suspension, 250mg/5ml, is here to help. This antibiotic suspension is specifically designed to alleviate symptoms and provide effective relief for conditions like exacerbations of chronic obstructive pulmonary disease (COPD) and broncho-pulmonary infections.
With its powerful 250mg/5ml concentration, Cipesta offers a strong defense against bacterial infections, ensuring you can breathe easier and feel better. Whether you’re an adult or a child, this medication is indicated for use in both age groups, providing a trusted solution for your health needs.
Choose Cipesta for its proven efficacy and reliability, and take the first step towards a healthier you.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Reviews
There are no reviews yet.